ALGIECEL™ | Securing CO2 Neutrality

+45 2248 5667

Send e-mail

Application

Vision

Securing CO2 Neutrality

Mission

Our goal is to remove millions of tonnes of CO2 annually from industrial production without hurting our clients´ bottom lines

Our Core Values

Planetary health is in everybody´s interest

Not bound by business as usual

Customer service is in our DNA

Work life balance & ownership mentality

Trust and support

Remember to have fun 

THE COMPANY TODAY

ALGIECEL was founded in May 2021 to secure industrial CO2 neutrality by implementation of microalgae-based Carbon Capture and Utilization (CCU).

We have recently finished the design, construction and installation of a pilot plant of our modular and easy-to-install PhotoBioReactor (PBR) solution at the Danish Technological Institute (DTI)

A skilled team with the necessary experience has been built. The company has received funding from the BioInnovation Institute (BII), and we participate in the Venture Lab program since March 2022. 

In January 2023, ALGIECEL closed a DKK 10 million (EUR 1.3m) seed round in combined funding from Denmark’s Export and Investment Fund and a UK-based family fund.

ALGIECEL has entered into supplier agreements with partners that hold key insights into areas such as LED light, biotech and plastic.

LOIs with potential clients and product end-users have been secured. A venue for the demo-scale project has been secured at a Novozymes facility.

 

THE PILOT PROJECT

In June 2022 ALGIECEL celebrated the opening of the mobile pilot plant at the Danish Technological Institute with more than 70 participants.

The day was dedicated to the green transition and sustainability with ALGIECEL´s development of a mobile container-based solution for the conversion of CO2 into biomass.

The pilot photobioreactor is now set up in cooperation with the DTI, which has secured access to laboratories, facilities and competencies within the microalgae cultivation area.

CEO Juan Farré from the DTI stated that “the opening marks the establishment by the DTI of an ecosystem giving start-up companies access to an integrated platform of testing and demonstration facilities within the space of future foods and the green transition”.

Earlier this year BII invested in ALGIECEL, and during the opening ceremony Jens Nielsen, the CEO of BII, kindly remarked: “I am impressed to see how rapidly ALGIECEL has advanced and is now initiating experiments at pilot scale. But speed is unfortunately important as we rapidly need new technologies like the ones ALGIECEL is providing to make sure that we can create a sustainable society. I congratulate them with their advancements, and I will be looking much forward to following them in the years to come”.

Meet the Management & Board

 

Management Team

Henrik Busch-Larsen

Henrik Busch-Larsen

CEO / Founder / Board Member

Entrepreneur, Strategy, Vision, Execution, Scale-up

Prior experience with
CEO Unibio Group, Co-founder A21 Systems, Various Board Positions

hbl@algiecel.com

Jesper Svarer

Jesper Svarer

CFO

Experience from international senior leadership roles within Finance, Strategy, M&A and business development.

Prior experience with:
Falck, KMD, A.P. Moller-Maersk, ISS, Handelsbanken

js@algiecel.com

Christian Kølby

Christian Kølby

CTO

Civil Engineer, MSc., Biotechnology and Aquaculture

Prior experience with:
Nestlé, SPX, Arla Foods Ingredients, Danisco, professional experience with pilot plants, R&D, food application technology and product management 

ck@algiecel.com

Gry Husby Larsen

Gry Husby Larsen

SVP Legal & HR

Lawyer, General Counsel

Prior experience with:
FluoGuide, BioPorto, Unibio, Knop & Co Advokater, DTU, Rigshospitalet

ghl@algiecel.com

Jens Odgaard Olsson

Jens Odgaard Olsson

Head of Commercial

Agricultural Value Chains, Experience Economics, Brand Development

Prior experience with:
Arla Foods, Carlsberg Group, Pernod Ricard & Lantmännen

joo@algiecel.com

Board of Directors

Martin Lavesen

Martin Lavesen

Chairman of the Board

Managing Partner @DLA Piper Denmark

Prior experience with:
+25 years as commercial lawyer focusing on IPR, Various board positions

Jeppe Høier

Jeppe Høier

Board Member

Investor

Investor background from:      Sunstone Life Science Ventures, Heartcore Maersk Growth. Led Unicorn rounds in companies such as Einride and Forto

Henrik Busch-Larsen

Henrik Busch-Larsen

CEO / Founder / Board Member

Advisory Board

Per Møller

Per Møller

Senior Symbiosis Developer @Kalundborg Symbiosis

Industrial Symbiosis, Marine Biology, Microalgae downstream processing, Chemical Engineering

Dr. Dorinde Kleinegris

Dr. Dorinde Kleinegris

Principal Investigator Microalgae @NORCE, Associate Prof. Marine Biotechnology at the University of Bergen (secondary position)

Bioprocess Engineering, Microalgae cultivation & strain selection, Techno-economic & LCA

Stephan Freyer

Stephan Freyer

Senior Research Manager @BASF

Bioprocess Development, Scale-Up, Fermentation, Media Optimization

Dr. Andreas Worberg

Dr. Andreas Worberg

CCO @The Novo Nordisk Foundation Center for BiosustainabilityCCO @DTU Biosustain, CTO @Cellugy ApS

Process Development in Biomanufacturing, Business Development

Michael Stannius Aagren

Michael Stannius Aagren

Digitalization Manager @Unibio

Industrial Production, Digitalization & IT

DIVERSITY POLICY

Algiecel is committed to continue working towards ensuring and furthering equal opportunities for all employees in respect of differences, such as gender, age, religion, sexual orientation and ethnicity, as all – in our view – serve as key components in ensuring a better, more dynamic and healthier business.  

The view extended through this policy also includes maintaining equal opportunities for women and men at all management levels in Algiecel. The Board of Directors annually discusses the company’s activities to ensure relevant diversity at management levels and evaluates the policy on diversity. 

Algiecel has defined a target, that no later than in 2025, at the composition of genders shall be no less than 25%/75% both in the Management of the Company and Board of Directors. This target must not detract from other competency requirements in the nomination of members to the Management team of the Company.   

Sign up for our newsletter

Sign up for our newsletter

Receive the latest news and updates from our team.

You have successfully subscribed! Please check your inbox.